Le Lézard
Classified in: Health
Subject: PER

Ameriflex reorganizes executive team to support sister company Accresa, drive innovation in benefits payment technology


DALLAS, Jan. 3, 2018 /PRNewswire/ -- Ameriflex today announced changes to the company's executive team to support sister company Accresa and explore opportunities for further growth and innovation in consumer-driven benefits and related fields. Ameriflex is an award-winning independent administrator of consumer-driven health plans.

Ameriflex

Anne Richter, Ameriflex's Chief Strategy Officer, has been named President of Accresa. In this role, she is responsible for building, managing, and executing on Accresa's strategic plan, with an emphasis on growth and business development. This is in addition to her continued role as CSO of Ameriflex, where she provides support for that company's global strategic plan and direction. Richter reports directly to William Short, CEO of both Ameriflex and Accresa.

Accresa launched in 2015 and focuses on direct primary care (DPC) payments. DPC is an emerging healthcare payment model based on a membership agreement between patients and doctors instead of the prevalent arrangement where doctors are paid via insurers according to service-based claims. The Accresa payments and technology platform is the first of its kind to capture and adapt all the advantages of a DPC model to fit within the framework of an employer's health benefits offering.

"After 20 years of benefits and payments innovation at Ameriflex, we launched Accresa to do what nobody else in our industry has accomplished: make direct primary care easily accessible within employee benefits plans," said Short. "Anne has been a core member of the Accresa team from the beginning and is perfectly suited to take on a more formal leadership role as the business evolves."

Ameriflex also recently hired David Rose in the new role of Chief Revenue Officer. Rose is responsible for the company's growth and revenue strategy, including day-to-day sales operations, annual growth plan, marketing, and strategic and channel partnerships. He is based in Dallas and reports to Ameriflex President and Chief Operating Officer Bart McCollum. Prior to joining Ameriflex, David consulted with business leaders around the world to help them grow revenue and profits, delivering over $4 billion in revenue to his clients.

"Our executive team at Ameriflex and Accresa is a dedicated, accomplished group with a proven track record for solving complex problems through technology?and building successful companies from scratch," added Short. "We see a great deal of opportunity in the marketplace, and that's driving the growth of our business and our team."

For more information about Accresa, visit www.accresa.com. For more information about Ameriflex, visit myameriflex.com.  

ABOUT ACCRESA:

The Accresa platform is the first of its kind to capture and adapt all the advantages of a direct primary care (DPC) model to fit within the framework of an employer's health benefits offering. Through its robust payments technology and easy-to-use administrative platform, Accresa connects employers and their employees with a growing national network of primary care physicians, clinics, medical groups, and health systems all focused on our shared vision for delivering a better healthcare experience. For more information about Accresa, visit www.accresa.com.

ABOUT AMERIFLEX:

Established in 1998, Ameriflex is an independent administrator providing technology-driven benefits, payment processing, and compliance solutions. Services provided include health spending account administration, supported by our consolidated debit card platform; COBRA administration and special plan billing services; and compliance services, including POP document generation. Headquartered in Dallas, Texas with an operations center in Cherry Hill, N.J., Ameriflex serves tens of thousands of clients representing millions of individual participants nationwide. For more information, visit myameriflex.com.

Michaela Morales
JConnelly
[email protected]
(646) 838-5442

Accresa

SOURCE Ameriflex


These press releases may also interest you

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:24
Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 1 phase III clinical trial in the United States. Concurrently, the identical INSPiRE-ICU 2 trial is nearing completion, with 23 of 235...



News published on and distributed by: